Supply of chemotherapy drugs such as Docetaxel

Supply of chemotherapy drugs such as Docetaxel

10 May 2013

© Commonwealth of Australia 2013
ISBN 978-1-74229-815-3

View the report as a single document - (PDF 262KB)

View the report as separate downloadable parts:

Spacer Image
Chapter 1 - Introduction (PDF 12KB)

Terms of Reference
Conduct of the Inquiry
Structure of the report

Chapter 2 - Background to Inquiry (PDF 42KB)
Operation of the PBS
The Fifth Community Pharmacy Agreement
Price Disclosure
Chemotherapy Drugs in the PBS
Chapter 3 - Chemotherapy funding (PDF 82KB)

Concerns raised by Private Providers
Negotiations concerning chemotherapy funding
   The 5th Community Pharmacy Agreement Negotiations
   Links between PBS Sustainability Measures
   Correspondence between the Department and the Pharmacy Guild
   Committee View

Coalition Senators' Additional comments (PDF 37KB)

A further delay on delivering funding certainty
Appropriateness of price disclosure
Poor understanding of significance of cross subsidisation in delivery of private chemotherapy services
Impact on access to cancer treatment for Australians living in regional areas
Abuse of good faith
The appropriateness of advocacy by providers and other health professionals
In Summary

Additional comments by Senator Nick Xenophon (PDF 31KB)

Impact on patients
Funding arrangements for chemotherapy drugs
Government consultation

APPENDIX 1 - Submissions and Additional Information received by the Committee (PDF 14KB)
APPENDIX 2 - Public Hearings (PDF 10KB)

For further information, contact:

Committee Secretary
Senate Standing Committees on Community Affairs
PO Box 6100
Parliament House
Canberra ACT 2600

Phone: +61 2 6277 3515
Fax: +61 2 6277 5829

Facebook LinkedIn Twitter Add | Email Print
Back to top